Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Oct 28;16(10):e0259068. doi: 10.1371/journal.pone.0259068

Identification of the centrosomal maturation factor SSX2IP as a Wtip-binding partner by targeted proximity biotinylation

Alice H Reis 1,#, Bo Xiang 1,¤,#, Olga Ossipova 1, Keiji Itoh 1, Sergei Y Sokol 1,*
Editor: Claude Prigent2
PMCID: PMC8553094  PMID: 34710136

Abstract

Wilms tumor-1-interacting protein (Wtip) is a LIM-domain-containing adaptor that links cell junctions with actomyosin complexes and modulates actomyosin contractility and ciliogenesis in Xenopus embryos. The Wtip C-terminus with three LIM domains associates with the actin-binding protein Shroom3 and modulates Shroom3-induced apical constriction in ectoderm cells. By contrast, the N-terminal domain localizes to apical junctions in the ectoderm and basal bodies in skin multiciliated cells, but its interacting partners remain largely unknown. Targeted proximity biotinylation (TPB) using anti-GFP antibody fused to the biotin ligase BirA identified SSX2IP as a candidate protein that binds GFP-WtipN. SSX2IP, also known as Msd1 or ADIP, is a component of cell junctions, centriolar satellite protein and a targeting factor for ciliary membrane proteins. WtipN physically associated with SSX2IP and the two proteins readily formed mixed aggregates in overexpressing cells. By contrast, we observed only partial colocalization of full length Wtip and SSX2IP, suggesting that Wtip adopts a ‘closed’ conformation in the cell. Furthermore, the double depletion of Wtip and SSX2IP in early embryos uncovered the functional interaction of the two proteins during neural tube closure. Our results suggest that the association of SSX2IP and Wtip is essential for cell junction remodeling and morphogenetic processes that accompany neurulation. We propose that TPB can be a general approach that is applicable to other GFP-tagged proteins.

Introduction

The Ajuba family of LIM-domain-containing proteins are adaptors that participate in various processes that involve actomyosin contractility. Ajuba localizes to adherens junctions and modulates Rac1 activity in mammalian cells [14]. At the junctions, Ajuba associates with α-catenin and inhibits Hippo signaling in a tension-dependent manner [57]. Also, Ajuba homologs localize to the centrosomes of mammalian and Drosophila cells and function in cell division and mitotic spindle orientation [1,8,9].

Wilms tumor 1-interacting protein (Wtip) is one of Ajuba homologues. Wtip is composed of two conserved domains that exhibit distinct properties. The C-terminus of Wtip contains three LIM domains and interacts with Shroom3, an actin binding protein that can ectopically induce apical constriction in different cell types [10,11]. Wtip also binds the core planar cell polarity (PCP) protein Prickle3 and has been implicated in PCP and ciliogenesis in Xenopus and zebrafish embryos [1214]. Furthermore, the C-terminal domain of Wtip has been found in the nucleus, where it is proposed to associate with transcriptional repressors of the Snail family and regulate transcription [15]. By contrast, the functions of the Wtip N-terminal domain that includes the first 480 amino acids of the protein (WtipN) are largely unknown. We find that the WtipN localizes to puncta at ectodermal cell junctions and to basal bodies in the epidermal multiciliated cells [14], however, the molecular mechanisms underlying its functions remain to be elucidated.

In this study, we searched for proteins associating with WtipN using a novel proximity biotinylation approach. The promiscuous bacterial biotin ligase BirA* has been fused with the GFP-specific single domain antibody, also known as GFP-binding protein (GBP) [16,17]. This fusion protein (BirA-GBP) would be expected to target the biotinylation activity to the immediate proximity of GFP-WtipN in vivo. This approach identified SSX2IP, also known as Msd1 and ADIP [18], as one of the main candidates. Interestingly, SSX2IP is a maturation factor for mitotic centrosomes [19], and a targeting factor for ciliary membrane proteins cooperating with Cep290, the BBSome, and Rab8 [20]. SSX2IP also interacts with Afadin and α-Actinin [18] and may link cell junctions to the actin cytoskeleton. This interaction of Wtip and SSX2IP has been further validated by the immunoprecipitation and the colocalization of the two proteins in ectoderm cells. We propose that the targeted proximity biotinylation (TPB) approach may help defining protein networks for other GFP-tagged proteins.

Materials and methods

Ethics statement

This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol 04–1295 was approved by the IACUC of the Icahn School of Medicine at Mount Sinai.

Plasmids, mRNA synthesis, morpholinos

WtipN encodes the N-terminal 480 amino acids of Xenopus Wtip. The plasmids for Xenopus Wtip including Flag-Wtip, GFP-WtipN, GFP-WtipC, HA-RFP-WtipN, HA-RFP-Wtip, Flag-WtipN, Flag-GFP, GFP-Prickle3C and Flag-Prickle3C have been previously described [12,14]. A plasmid encoding a mutated myc-BirA [21], a gift from Brian Burke, was subcloned into pCS2 vector. WtipN was fused to BirA by subcloning in pCS2-myc-BirA vector to generate WtipN-MycBirA. BirA DNA was fused to the N-terminus of the DNA fragment encoding a single domain antibody specific for GFP [17] in pCS2 vector (BirA-GBP). The insert from the human Msd1/SSX2IP plasmid (a gift from T. Toda) was subcloned into pCS2-GFP vector to make GFP-hSSX2IP. Xenopus SSX2IP cDNA clone (SSX2IP.S) was obtained from Dharmacon and the insert was subcloned into pXT7-EGFP to make GFP-XSSX2IP-pXT7. Details of cloning are available upon request. Capped mRNAs were made by in vitro transcription from linearized plasmids as templates with T7 or SP6 RNA polymerases using mMessage mMachine kit (Ambion). Wtip morpholino (WMO) has been described previously (Chu et al., 2016), Xenopus SSX2IP MO (SMO) was purchased from GeneTools and had the following sequence: 5’- TAACTCCTCGACTCCTTCTGGACAG-3’.

Xenopus embryo culture, microinjections and neural tube closure analysis

In vitro fertilization and culture of Xenopus laevis embryos were carried out as previously described [22]. Staging was according to [23]. For microinjections, four-cell embryos were transferred into 3% Ficoll in 0.5 x MMR buffer and 10 nl of mRNAs with or without biotin solution was injected into one or more blastomeres. Amounts of injected mRNA or biotin per embryo have been optimized in preliminary dose-response experiments and are indicated in figure legends.

For neural tube closure analysis, embryos were unilaterally injected with suboptimal doses of Wmo or Smo (10 ng each, as determined in prior studies) or with the mixture of these morpholinos. Neural fold formation in the injected embryos was monitored at neurula stage 18–19 at the time of neural tube closure. The results are presented for three independent experiments.

Immunoblot analysis

Immunoblotting was carried out as previously described [24]. Briefly, whole embryos were lysed in the lysis buffer containing 1% Triton X-100, 50 mM sodium chloride, 50 mM Tris-HCl at pH 7.6, 1 mM EDTA, 0.6 mM phenylmethylsulphonyl fluoride (PMSF), 10 mM sodium fluoride and 1 mM sodium orthovanadate. Proteins were separated by SDS-polyacrylamide gel electrophoresis and transferred to the PVDF membrane for immunodetection. Antibodies against the following antigens were used: myc (1:200, mouse monoclonal 9E10 hybridoma supernatant), His (1:1000, mouse monoclonal, Invitrogen), Flag M2(1:1000, mouse monoclonal, Sigma), GFP (1:1000, B-2 mouse monoclonal, Santa Cruz). Secondary antibodies were against mouse or goat IgG conjugated to HRP (1:3000, Jackson Immunoresearch or Santa Cruz). Biotinylated proteins were detected similarly with the following modifications. Membranes were blocked in 3% nonfat milk in PBS with 0.1% Tween 20 and incubated in the same buffer with HRP-conjugated streptavidin (1:5,000, Invitrogen).

For co-immunoprecipitation of Flag-tagged Wtip or GFP constructs with GFP-hSSX2IP, 30 embryos at 4–8 cell stages were injected with 300 pg Flag-Wtip, Flag-WtipN or Flag-GFP and 300 pg GFP-hSSX2IP RNA into four animal blastomeres. When control embryos reached stage 11, embryos were lysed in 500 μl of the lysis buffer and cleared by centrifugation at 16,000 g for 4 min. The supernatant was incubated with 2 μl of anti-Flag M2 agarose beads overnight at 4°C. After washing the beads, 2 x SDS sample buffer was added, heated and the samples were analyzed by immunoblotting.

Affinity capture of biotinylated proteins

One hundred embryos at the 4-8-cell stage were injected four times into animal blastomeres with 10 nl of RNA (200 ng) mixed with Biotin (1.2 mM). The embryos were cultured until st. 12.5 or st. 14. Then, the embryos were lysed in 1 ml of the lysis buffer and the lysates were centrifuged at 16,000 g for 4 min. Supernatants were incubated with 40 μl neutravidin beads (Invitrogen) at 4°C overnight. The beads were washed with PBS four times, the bound proteins were eluted by 50 μl of the SDS-sample buffer and heating at 98°C for 5 min. 10% of the sample was reserved for immunoblotting. For preparative scale, 90% of the sample were loaded on a gel.

Protein identification by mass spectrometry

Proteins eluted from the avidin beads by boiling in the SDS containing sample buffer and separated by SDS-PAGE using standard procedures [24]. Separated proteins were visualized by Coomassie Blue staining. The whole gel lanes were cut in several gel bands and submitted to in-gel trypsin digestion and LC-MS/MS analysis at the Keck Proteomics Laboratory (Yale University). Data were annotated using Xenopus laevis genome version 9.2 at Xenbase (www.xenbase.org). The results were analyzed by the Scaffold software. The acceptance level for proteins was two identified peptides with minimum 95% probability each.

Fluorescent protein colocalization in ectoderm explants

Four-to-eight cell embryos were injected with RNAs encoding HA-RFP-WtipN, HA-RFP-Wtip and/or GFP-XSSX2IP (50–300 pg each). When the embryos reached stages 10.5 or 12.5, ectoderm has been dissected, fixed and mounted for imaging. Fluorescent images of protein aggregates were captured using AxioImager microscope (Zeiss) and Axiovision imaging software. Each experimental group had 7–15 embryos for three independent experiments.

Results

WtipN is localized to the basal bodies of multiciliated skin cells

We have previously described the subcellular distribution of Wtip in junctional puncta in epidermal ectoderm and neuroectoderm at late gastrula/early neurula stages [14] and at the basal bodies of ciliated endoderm cells of the Xenopus gastrocoel roof [12]. We further explored the localization of WtipN, encoding the first 480 amino acids of the protein, in embryos microinjected with GFP-WtipN RNA. In early gastrula ectoderm, GFP-WtipN was detected at cell junctions (Fig 1A and 1B). At tailbud stages, GFP-WtipN localized to basal bodies of skin multiciliated cells as well as cell junctions (Fig 1C). These findings are consistent with our previous observations [12,14], however the proteins targeting WtipN to the centrosome or cell junctions have not been identified.

Fig 1. Biotinylation of the BirA-WtipN fusion in Xenopus embryos.

Fig 1

A, Schematic of Wtip. B, C, Embryos were injected with 200 pg of GFP-WtipN RNA, fixed and imaged at the indicated stages. B, GFP-WtipN junctional staining in stage 11 ectoderm. C, GFP-WtipN is localized to basal bodies of skin multiciliated cells (arrows, stage 25). Scale bar, 20 μm. D, Biotinylation of the BirA-WtipN fusion. Four-cell embryos were injected with myc-BirA RNA (300 pg) or mycBirA-WtipN RNA (700 pg) with or without 0.8 mM biotin. Self-biotinylation of mycBirA and mycBirA-WtipN is revealed only in the presence of biotin. Protein levels were assessed with anti-myc antibody. Asterisks indicate endogenous avidin-binding proteins. E. Biotinylated proteins were pulled down with neutravidin beads. In addition to self-biotinylated mycBirA-Wtip, multiple biotinylated bands are detected in the lysates as well as in pulldown.

BirA and the BirA-WtipN fusion is active in Xenopus embryos

To search for new interacting partners of Wtip, we decided to use proximity biotinylation that allows to isolate associated proteins by labeling them in vivo with biotin using a mutated E. coli biotin ligase BirA [21]. We generated a fusion of BirA with WtipN (myc-BirA-WtipN) and tested its enzymatic activity in Xenopus embryos. Early embryos were injected with myc-BirA or myc-BirA-WtipN RNA with or without biotin and cultured until neurula stages. We observed robust self-biotinylation of both myc-BirA-WtipN and myc-BirA in the presence of biotin, confirming that BirA is active both on its own and as a fusion (Fig 1D). Notably, in the absence of biotin, the background was low, except for two major protein bands around 70 and 120 kDa recognized by Streptavidin-HRP, possibly representing endogenous biotin-containing proteins. Pulldowns with neutravidin beads contained many additional bands in the sample from myc-BirA-WtipN-expressing embryos (Fig 1E), presumably corresponding to WtipN-interacting proteins. These results suggest that BirA can be used directly for proximity biotinylation in Xenopus, complementing previous observations for this and other models [2528].

Targeted proximity biotinylation

We next modified the approach by fusing BirA to the coding sequence of a single domain antibody against GFP, or GFP-binding protein [16,17]. Such fusion (BirA-GBP) would be predicted to biotinylate any GFP-tagged protein and other proteins in its immediate proximity. This construct would serve as a universal tool for targeted proximity biotinylation (TPB). To validate the efficiency and specificity of this approach, we injected BirA-GBP RNA into early embryos together with GFP-WtipN and Flag-WtipN.

As expected, we observed an efficient and specific biotinylation of GFP-WtipN but not Flag-WtipN, when these were coexpressed with BirA-GBP and biotin (Fig 2A). Of note, BirA-GBP failed to biotinylate Flag-GFP, possibly due to lack of suitable lysine residues (Fig 2A). To show that TPB can be applied to a different protein, we confirmed that BirA-GBP biotinylates GFP-Prickle3C but not Flag-Prickle3C [12] (Fig 2B). These results suggest that TPB may be useful for protein network analysis for GFP-tagged proteins in general.

Fig 2. Specificity of BirA-GBP-mediated biotinylation.

Fig 2

A, GFP-WtipN but not Flag-WtipN is biotinylated (left arrow) by BirA-GBP in the presence of biotin. MycBirA-WtipN is a positive control for biotinylation (right arrow). B, GFP-Prickle3C protein, but not Flag-Prickle3C, was biotinylated by BirA-GBP. Protein expression levels are assessed with tag-specific antibodies as indicated (A, B).

Identification of SSX2IP/Msd1/ADIP as a novel interacting partner of WtipN

To search for proteins interacting with WtipN, we carried out TPB in vivo, in embryos coexpressing GFP-WtipN and BirA-GBP in the presence of biotin (Fig 3A). Embryos coexpressing Flag-WtipN and BirA-GBP were used as negative controls (Fig 3B). A separate group of embryos was injected with Myc-BirA-WtipN. Biotinylated proteins were captured with neutravidin-agarose beads, the bound proteins were separated by SDS-PAGE and visualized by Simple Blue staining. Gel slices were analyzed by LC-MS/MS to identify candidate interacting proteins. This analysis identified several proteins that were present in the group of GFP-WtipN and BirA-GBP, but absent in the group with Flag-WtipN and BirA-GBP (Fig 3C). Multiple identified peptides belonged to the Xenopus homologue of SSX2IP/ADIP/Msd1 [18,19,29]. The same protein was identified at high confidence using Myc-BirA-WtipN as a bait (Fig 3C). These findings indicate that SSX2IP and WtipN interact.

Fig 3. Identification of SSX2IP by targeted proximity biotinylation.

Fig 3

A, Scheme of targeted proximity biotinylation (TPB) with GFP-WtipN. Early embryos were injected with indicated RNAs (200 pg each) and biotin (1.2 mM). B, Biotinylated proteins were enriched with neutravidin agarose beads and immunoblotted with indicated antibodies. Biotinylated GFP-WtipN (asterisk) but not Flag-WtipN in the presence of BirA-GBP was detected in the pulldown. MycBirA-WtipN (asterisk) was biotinylated in the absence of BirA-GBP. C, Top hits identified by SCAFFOLD after LC-MS/MS analysis in both experimental groups but not in the negative control group.

SSX2IP associates with WtipN in embryonic ectoderm

We next validated the identified interaction by co-immunoprecipitation (Fig 4). Flag-WtipN protein strongly associated with GFP-SSX2IP protein at the beginning of gastrulation when co-expressed in Xenopus embryos. Of note, the full length Wtip protein was less efficient in the binding of GFP-SSX2IP protein (Fig 4). These experiments strongly suggest that SSX2IP associates with WtipN in vivo. Consistent with this possibility, both Wtip and SSX2IP have been found at or near the basal bodies [12,14,20,30].

Fig 4. The physical association of SSX2IP and Wtip.

Fig 4

Four-cell embryos were coinjected with GFP-hSSX2IP RNA and either Flag-WtipN or Flag-Wtip RNA (300 pg each). Flag-GFP RNA (300 pg) was the negative control. Embryos were lysed at stage 11 and lysates were immunoprecipitated with anti-Flag agarose beads and immunoblotted with antibodies specific for Flag and GFP. WtipN coprecipitated with SSX2IP more efficiently than full length Wtip.

We next evaluated the subcellular distribution of SSX2IP in ectodermal cells. In embryos injected with low doses of GFP-SSX2IP RNA (50 pg), SSX2IP is distributed to puncta adjacent to the cell cortex at the beginning of gastrulation (Fig 5A and 5B). By the end of gastrulation, SSX2IP accumulated in spherical cytoplasmic aggregates of variable size (Fig 5C). Given that Wtip and WtipN also form cytoplasmic and cortical aggregates (Fig 5D, 5E and 5G), we asked whether they would colocalize with SSX2IP. We observed that GFP-SSX2IP and HA-RFP-WtipN puncta readily colocalized in the cytoplasm of ectoderm cells (Figs 5F–5F” and S1). The SSX2IP/WtipN protein complexes increased in size at higher doses of RNAs (S1 Fig). Notably, full length HA-RFP-Wtip showed only limited colocalization with SSX2IP (Fig 5H–5H”). Together these experiments suggest that SSX2IP binds the N-terminal fragment of Wtip and likely modulates its function at the same subcellular location, such as the centrosome or cell junctions.

Fig 5. SSX2IP and WtipN co-aggregate in ectoderm cells.

Fig 5

A, Experimental scheme. HA-RFP-Wtip or HA-RFP-WtipN RNA (50 pg each) was coinjected with GFP-SSX2IP RNA (50 pg) into four-cell embryos. When the embryos reached stage 10 or 12.5, ectoderm was dissected, fixed, and fluorescent protein localization at the cortex and cytoplasmic puncta was imaged at indicated stages. B, GFP-SSX2IP, stage 10.5. C, GFP-SSX2IP, stage 12.5. D, HA-RFP-Wtip, stage 10.5. E, HA-RFP-WtipN, stage 12.5. F-F”, Mixed cytoplasmic aggregates (arrows) in cells coexpressing GFP-SSX2IP and RFP-WtipN, stage 12.5. F, red channel, F’ green channel, F”, merged image. G, HA-RFP-Wtip, stage 12.5. H-H”, Partial colocalization of GFP-SSX2IP and HA-RFP-Wtip in cytoplasmic puncta (arrows). Scale bar, 15 μm. Images are representative of 3 independent experiments, with 10–15 embryos imaged per group in each experiment.

Functional interaction of SSX2IP and Wtip during neural tube closure

Since both Wtip and SSX2IP associate with cell junctions and Wtip has been implicated in neural tube closure [14,18], we wanted to test whether the two proteins functionally interact. We therefore evaluated the phenotype of the morphants depleted of both Wtip and SSX2IP using translation-blocking MOs. Injection of moderate doses (10–30 ng) of SSX2IP-specific MO caused neural tube closure defects consistent with the suspected role of SSX2IP in neurulation. This phenotype has been partly rescued by the coinjection of human SSX2IP RNA, although we noticed considerable variability in this assay in different experiments (Fig 6A–6F). Whereas each MO had only a mild effect on neural tube closure, neural folding has been severely affected in embryos injected with both MOs (Fig 6G–6L). Our observations indicate that SSX2IP and Wtip functionally interact in neural tube closure.

Fig 6. SSX2IP and Wtip functionally interact to promote neural tube closure.

Fig 6

Embryos were injected bilaterally or unilaterally with 10 ng of Wtip MO (Wmo) or SSX2IP MO (Smo) or 20 pg of human SSX2IP RNA as indicated. Neural groove formation along the anteroposterior axis was assessed at stages 16–18. A-F, Neural tube closure defects in SSX2IP morphants. A, Scheme of the experiment. B-D, Dorsal views of representative embryos at stages 16–17, anterior is up. B, Control uninjected embryo, C, SSX2IP RNA injection. D, Embryo injected with Smo. E, Embryo injected with Smo and SSX2IP RNA. Human SSX2IP RNA partly rescues neural closure defects. Dashed lines indicate neural fold borders. F, Frequency of neural tube (NT) defects. Data are representative of two experiments. G-L, Functional interaction of SSX2IP and Wtip. G, Scheme of the experiment. H-L, Representative embryos at stages 18–19 injected with control MO (CoMO, H), Wmo (I), Smo (J) or both Wmo and Smo (K). Midline, white dashed line, neural fold border, magenta dashed line. Anterior is up. L, Frequency of neural tube (NT) defects in the morphants. Data represent three different experiments. In F and L, total number of embryos per group is shown above each bar. Mild, severe and normal phenotypes have been scored separately, with examples shown in L.

Discussion

In this study, we used targeted proximity biotinylation to search for new interaction partners of Wtip, a LIM-domain protein of the Ajuba/Zyxin family. Wtip is present in many tissues and has been shown to localize to the centrosome/basal bodies and cell junctions [12,14]. This diverse localization may underlie the proposed functions of Wtip in morphogenesis and planar cell polarity as well as its roles in the centrosomal organization and ciliogenesis [1214]. Wtip has been also implicated in forming a complex with the Snail transcription factors leading to the activation of neural crest markers [15]. The knowledge of new interaction partners of Wtip should help elucidate how it functions in the cell.

Proximity biotinylation or BioID (biotin identification) is a useful method for detecting weak and transient protein interactions under physiological conditions. This approach overcomes non-specific contamination that often accompanies traditional pulldowns and is more sensitive and specific as compared to conventional immunoprecipitations or yeast-two-hybrid screens [31]. We modified this technique by fusing BirA with GBP, an anti-GFP antibody that brings the enzyme into close proximity with GFP-WtipN. One advantage of our approach is that the generation of the direct fusion of the ‘bait’ protein with BirA is no longer needed. Also, this method may identify a more diverse protein population due to the increased distance or spatial flexibility between the enzyme and the bait. Importantly, SSX2IP has been detected by targeting BirA-GBP to GFP-WtipN and by the direct fusion protein WtipN-BirA, increasing our confidence in the result. Based on our results and a similar study using zebrafish embryos [32], we propose that TPB is a versatile general technique that is applicable for protein interaction studies of GFP-tagged proteins. However, lack of biotinylation of Flag-GFP in our experiments suggests possible sterical hindrance of the epitope or lack of lysine residues needed for biotinylation, indicating that not all proteins are suitable targets for this approach.

Our analysis identified SSX2IP/ADIP/Msd1 as a protein associating with the N-terminus of Wtip. SSX2IP is a conserved centriolar satellite protein that anchors microtubules to the centrosome [29] and functions in ciliogenesis [30]. We validated the binding of WtipN to SSX2IP using immunoprecipitation and in vivo colocalization of the two proteins. The implication of both Wtip and SSX2IP in ciliogenesis [13,30] suggests a potential role of this interaction in PCP signaling. Notably, upon coexpression, WtipN and SSX2IP formed mixed spherical cytoplasmic aggregates of the size dependent on the dose of injected RNAs. By contrast, full length Wtip only partly colocalized with SSX2IP, suggesting that the protein might be present in a closed conformation caused by the interaction of the N- and C-terminal fragments [14]. The aggregation of WtipN and SSX2IP is similar to known cases of liquid phase separation that has been observed for the centrosome assembly both in vitro and in vivo [3335]. The physiological significance of these observations and the mechanism regulating Wtip conformational changes remain to be clarified in future studies.

Like SSX2IP, Wtip is present at the centrosome and basal bodies of different cell types and appears to require its N-terminus for this localization [12,14]. Thus, the interaction of Wtip with SSX2IP may be a prerequisite for the centrosomal/basal body localization for one or the other protein or may be relevant for the assembly of the pericentriolar material. Besides the roles at the centrosome and/or basal body, the association of Wtip and SSX2IP may play a role in actomyosin dynamics during junction remodeling. Both proteins interact with tension-sensitive molecules that organize actomyosin complexes at cell junctions [14,18]. Consistent with the roles at cell junctions, we observed the functional interaction of the two proteins during neural tube closure. Further analysis is needed to demonstrate how SSX2IP contributes to regulation of actomyosin contractility.

Supporting information

S1 Fig. Colocalization of SSX2IP and WtipN in ectoderm cells.

A, Experimental scheme. RFP-WtipN RNA (300 pg) and GFP-XSSX2IP RNA (300 pg) were coinjected into four-cell embryos. When the embryos reached stage 12.5, they were fixed, and the ectodermal tissue was imaged. B, GFP-SSX2IP localization in ectoderm cells. SSX2IP colocalizes with WtipN in cytoplasmic puncta. C, RFPWtipN localization at the junctions and cytoplasmic puncta. D-D”, Coexpression of both proteins revealed mixed cytoplasmic aggregates (arrow). Scale bar, 15 μm. Data are representative of 3 independent experiments.

(PDF)

S2 Fig. Full gel images.

(PDF)

Acknowledgments

We thank T. Toda for the hMsd1 plasmid. We also thank Andriani Ioannou and Fei Wu for their contributions at the early stages of this work, Miho Matsuda for advice and help with imaging of fluorescent protein localization, and members of the Sokol laboratory for discussions. We acknowledge the help of the Keck Proteomics Laboratory in protein identification by LS-MS/MS.

Data Availability

All relevant data are within the paper.

Funding Statement

This study has been supported by the National Institutes of Health grant R35 GM122492 to SYS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Schimizzi GV, Longmore GD. Ajuba proteins. Curr Biol. 2015;25(11):R445–6. doi: 10.1016/j.cub.2015.02.034 . [DOI] [PubMed] [Google Scholar]
  • 2.Kadrmas JL, Beckerle MC. The LIM domain: from the cytoskeleton to the nucleus. Nat Rev Mol Cell Biol. 2004;5(11):920–31. Epub 2004/11/03. nrm1499 [pii] doi: 10.1038/nrm1499 . [DOI] [PubMed] [Google Scholar]
  • 3.Marie H, Pratt SJ, Betson M, Epple H, Kittler JT, Meek L, et al. The LIM protein Ajuba is recruited to cadherin-dependent cell junctions through an association with alpha-catenin. J Biol Chem. 2003;278(2):1220–8. Epub 2002/11/06. doi: 10.1074/jbc.M205391200 M205391200 [pii]. . [DOI] [PubMed] [Google Scholar]
  • 4.Pratt SJ, Epple H, Ward M, Feng Y, Braga VM, Longmore GD. The LIM protein Ajuba influences p130Cas localization and Rac1 activity during cell migration. J Cell Biol. 2005;168(5):813–24. Epub 2005/02/25. jcb.200406083 [pii] doi: 10.1083/jcb.200406083 ; PubMed Central PMCID: PMC2171823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Rauskolb C, Sun S, Sun G, Pan Y, Irvine KD. Cytoskeletal tension inhibits Hippo signaling through an Ajuba-Warts complex. Cell. 2014;158(1):143–56. Epub 2014/07/06. S0092-8674(14)00722-3 [pii] doi: 10.1016/j.cell.2014.05.035 ; PubMed Central PMCID: PMC4082802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Das Thakur M, Feng Y, Jagannathan R, Seppa MJ, Skeath JB, Longmore GD. Ajuba LIM proteins are negative regulators of the Hippo signaling pathway. Curr Biol. 2010;20(7):657–62. Epub 2010/03/23. S0960-9822(10)00223-X [pii] doi: 10.1016/j.cub.2010.02.035 ; PubMed Central PMCID: PMC2855397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Nola S, Daigaku R, Smolarczyk K, Carstens M, Martin-Martin B, Longmore G, et al. Ajuba is required for Rac activation and maintenance of E-cadherin adhesion. J Cell Biol. 2011;195(5):855–71. Epub 2011/11/23. jcb.201107162 [pii] doi: 10.1083/jcb.201107162 ; PubMed Central PMCID: PMC3257575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Hirota T, Kunitoku N, Sasayama T, Marumoto T, Zhang D, Nitta M, et al. Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells. Cell. 2003;114(5):585–98. Epub 2003/09/19. S0092867403006421 [pii]. doi: 10.1016/s0092-8674(03)00642-1 . [DOI] [PubMed] [Google Scholar]
  • 9.Sabino D, Brown NH, Basto R. Drosophila Ajuba is not an Aurora-A activator but is required to maintain Aurora-A at the centrosome. J Cell Sci. 2011;124(Pt 7):1156–66. Epub 2011/03/16. doi: 10.1242/jcs.076711 [pii] ; PubMed Central PMCID: PMC3056608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Haigo SL, Hildebrand JD, Harland RM, Wallingford JB. Shroom induces apical constriction and is required for hingepoint formation during neural tube closure. Curr Biol. 2003;13(24):2125–37. Epub 2003/12/19. S0960982203009102 [pii]. doi: 10.1016/j.cub.2003.11.054 . [DOI] [PubMed] [Google Scholar]
  • 11.Hildebrand JD, Soriano P. Shroom, a PDZ domain-containing actin-binding protein, is required for neural tube morphogenesis in mice. Cell. 1999;99(5):485–97. Epub 1999/12/10. S0092-8674(00)81537-8 [pii]. doi: 10.1016/s0092-8674(00)81537-8 . [DOI] [PubMed] [Google Scholar]
  • 12.Chu CW, Ossipova O, Ioannou A, Sokol SY. Prickle3 synergizes with Wtip to regulate basal body organization and cilia growth. Sci Rep. 2016;6:24104. doi: 10.1038/srep24104 ; PubMed Central PMCID: PMC4827067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Bubenshchikova E, Ichimura K, Fukuyo Y, Powell R, Hsu C, Morrical SO, et al. Wtip and Vangl2 are required for mitotic spindle orientation and cloaca morphogenesis. Biol Open. 2012;1(6):588–96. Epub 2012/12/06. doi: 10.1242/bio.20121016 BIO20121016 [pii]. ; PubMed Central PMCID: PMC3509438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Chu CW, Xiang B, Ossipova O, Ioannou A, Sokol SY. The Ajuba family protein Wtip regulates actomyosin contractility during vertebrate neural tube closure. J Cell Sci. 2018;131(10). Epub 2018/04/18. doi: 10.1242/jcs.213884 ; PubMed Central PMCID: PMC6031329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Langer EM, Feng Y, Zhaoyuan H, Rauscher FJ 3rd, Kroll KL, Longmore GD. Ajuba LIM proteins are snail/slug corepressors required for neural crest development in Xenopus. Dev Cell. 2008;14(3):424–36. Epub 2008/03/12. S1534-5807(08)00033-6 [pii] doi: 10.1016/j.devcel.2008.01.005 ; PubMed Central PMCID: PMC2279146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Rothbauer U, Zolghadr K, Muyldermans S, Schepers A, Cardoso MC, Leonhardt H. A versatile nanotrap for biochemical and functional studies with fluorescent fusion proteins. Mol Cell Proteomics. 2008;7(2):282–9. Epub 2007/10/24. doi: 10.1074/mcp.M700342-MCP200 . [DOI] [PubMed] [Google Scholar]
  • 17.Kubala MH, Kovtun O, Alexandrov K, Collins BM. Structural and thermodynamic analysis of the GFP:GFP-nanobody complex. Protein Sci. 2010;19(12):2389–401. Epub 2010/10/15. doi: 10.1002/pro.519 ; PubMed Central PMCID: PMC3009406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Asada M, Irie K, Morimoto K, Yamada A, Ikeda W, Takeuchi M, et al. ADIP, a novel Afadin- and alpha-actinin-binding protein localized at cell-cell adherens junctions. J Biol Chem. 2003;278(6):4103–11. Epub 2002/11/26. doi: 10.1074/jbc.M209832200 . [DOI] [PubMed] [Google Scholar]
  • 19.Barenz F, Inoue D, Yokoyama H, Tegha-Dunghu J, Freiss S, Draeger S, et al. The centriolar satellite protein SSX2IP promotes centrosome maturation. J Cell Biol. 2013;202(1):81–95. Epub 2013/07/03. doi: 10.1083/jcb.201302122 ; PubMed Central PMCID: PMC3704989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Klinger M, Wang W, Kuhns S, Barenz F, Drager-Meurer S, Pereira G, et al. The novel centriolar satellite protein SSX2IP targets Cep290 to the ciliary transition zone. Mol Biol Cell. 2014;25(4):495–507. Epub 2013/12/21. doi: 10.1091/mbc.E13-09-0526 ; PubMed Central PMCID: PMC3923641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Roux KJ, Kim DI, Raida M, Burke B. A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells. J Cell Biol. 2012;196(6):801–10. doi: 10.1083/jcb.201112098 ; PubMed Central PMCID: PMC3308701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Dollar GL, Weber U, Mlodzik M, Sokol SY. Regulation of Lethal giant larvae by Dishevelled. Nature. 2005;437(7063):1376–80. doi: 10.1038/nature04116 . [DOI] [PubMed] [Google Scholar]
  • 23.Nieuwkoop PD, Faber J. Normal Table of Xenopus laevis (Daudin). Amsterdam: North Holland; 1967.
  • 24.Itoh K, Brott BK, Bae GU, Ratcliffe MJ, Sokol SY. Nuclear localization is required for Dishevelled function in Wnt/beta-catenin signaling. J Biol. 2005;4(1):3. Epub 2005/02/22. doi: 10.1186/jbiol20 ; PubMed Central PMCID: PMC551520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Branon TC, Bosch JA, Sanchez AD, Udeshi ND, Svinkina T, Carr SA, et al. Efficient proximity labeling in living cells and organisms with TurboID. Nat Biotechnol. 2018;36(9):880–7. Epub 2018/08/21. doi: 10.1038/nbt.4201 ; PubMed Central PMCID: PMC6126969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Chuykin I, Ossipova O, Sokol SY. Par3 interacts with Prickle3 to generate apical PCP complexes in the vertebrate neural plate. Elife. 2018;7. Epub 2018/09/27. doi: 10.7554/eLife.37881 ; PubMed Central PMCID: PMC6175575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Hung V, Udeshi ND, Lam SS, Loh KH, Cox KJ, Pedram K, et al. Spatially resolved proteomic mapping in living cells with the engineered peroxidase APEX2. Nat Protoc. 2016;11(3):456–75. Epub 2016/02/13. doi: 10.1038/nprot.2016.018 ; PubMed Central PMCID: PMC4863649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Pronobis MI, Zheng S, Singh SP, Goldman JA, Poss KD. In vivo proximity labeling identifies cardiomyocyte protein networks during zebrafish heart regeneration. Elife. 2021;10. Epub 2021/03/26. doi: 10.7554/eLife.66079 ; PubMed Central PMCID: PMC8034980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Toya M, Sato M, Haselmann U, Asakawa K, Brunner D, Antony C, et al. Gamma-tubulin complex-mediated anchoring of spindle microtubules to spindle-pole bodies requires Msd1 in fission yeast. Nat Cell Biol. 2007;9(6):646–53. Epub 2007/05/09. doi: 10.1038/ncb1593 . [DOI] [PubMed] [Google Scholar]
  • 30.Hori A, Ikebe C, Tada M, Toda T. Msd1/SSX2IP-dependent microtubule anchorage ensures spindle orientation and primary cilia formation. EMBO Rep. 2014;15(2):175–84. Epub 2014/01/09. doi: 10.1002/embr.201337929 ; PubMed Central PMCID: PMC3989863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Roux KJ, Kim DI, Burke B, May DG. BioID: A Screen for Protein-Protein Interactions. Curr Protoc Protein Sci. 2018;91:19 23 1–19 23 15. Epub 2018/03/09. doi: 10.1002/cpps.51 ; PubMed Central PMCID: PMC6028010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Xiong Z, Lo HP, McMahon KA, Martel N, Jones A, Hill MM, et al. In vivo proteomic mapping through GFP-directed proximity-dependent biotin labelling in zebrafish. Elife. 2021;10. Epub 2021/02/17. doi: 10.7554/eLife.64631 ; PubMed Central PMCID: PMC7906605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Woodruff JB, Wueseke O, Viscardi V, Mahamid J, Ochoa SD, Bunkenborg J, et al. Centrosomes. Regulated assembly of a supramolecular centrosome scaffold in vitro. Science. 2015;348(6236):808–12. Epub 2015/05/16. doi: 10.1126/science.aaa3923 ; PubMed Central PMCID: PMC5039038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Wheeler RJ, Hyman AA. Controlling compartmentalization by non-membrane-bound organelles. Philos Trans R Soc Lond B Biol Sci. 2018;373(1747). Epub 2018/04/11. doi: 10.1098/rstb.2017.0193 ; PubMed Central PMCID: PMC5904305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Alberti S, Hyman AA. Biomolecular condensates at the nexus of cellular stress, protein aggregation disease and ageing. Nat Rev Mol Cell Biol. 2021;22(3):196–213. Epub 2021/01/30. doi: 10.1038/s41580-020-00326-6 . [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Claude Prigent

11 Aug 2021

PONE-D-21-20125

Identification of SSX2IP as a Wtip-binding partner bytargeted proximity biotinylation

PLOS ONE

Dear Dr. Sokol,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please perform co-localization with full length Wtip

Please try to use using lower amounts of mRNA injected (say 4x50, max 4x100pg) to reveal a more physiological distribution/co-localization.

Please try to rescue MO phenotypes by co-injection of the corresponding mRNA.

Please revise the use of synergy to describe the effect of Wtip - SSX2IP co-depletion

Please submit your revised manuscript by Sep 23 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Claude Prigent

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.

In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: see attachment, I paste here only the first paragraph

This is an interesting report of a new interaction between the limb domain adaptor protein Wtip (Ajuba family) implicated at the interface between the actin cytoskeleton and cell junctions, and also implicated in ciliogenesis, and SSX2IP, a protein that involved in microtubule-centrosome interactions. Specifically, the authors were looking for interactors of the N-term of Wtip, which they had previously found to be crucial for localization both at cell-cell junctions and at cilia basal bodies..................

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PloSOne-Reis et al.docx

PLoS One. 2021 Oct 28;16(10):e0259068. doi: 10.1371/journal.pone.0259068.r002

Author response to Decision Letter 0


13 Sep 2021

PONE-D-21-20125. Response to Reviews.

Identification of SSX2IP as a Wtip-binding partner by targeted proximity biotinylation

We first wish to thank the referee and the editor for the constructive comments that helped improve our manuscript.

Point-by-point responses to referee 1

This is an interesting report of a new interaction between the limb domain adaptor protein Wtip (Ajuba family) implicated at the interface between the actin cytoskeleton and cell junctions, and also implicated in ciliogenesis, and SSX2IP, a protein that involved in microtubule-centrosome interactions. Specifically, the authors were looking for interactors of the N-term of Wtip, which they had previously found to be crucial for localization both at cell-cell junctions and at cilia basal bodies.

The interaction was first identified by biotinylation, pulldown and proteomics, using a protocol based on fusing an anti-GFP nanobody to the biotin ligase BirA. The authors comment on the utility of this new protocol, as it avoids fusing each bait protein with BirA, as done in standard biotinylation methods. One should note, however, that this method has its own caveats, as it failed to biotinylate a simple Flag-tagged GFP. This in my view hint at steric hindrance and/or epitope marking, which may depend on the type of GFP-fusion protein. One would wish to see this caveat included in the discussion.

We discuss this issue in the amended text (pp. 14, top) as suggested by the reviewer.

As for the interaction Wtip - SSX2IP, the interaction appears robust, as validated by co-immunoprecipitation. How direct/indirect is the interaction was not investigated. A simple protein staining (silver stain?) of an SDSPAGE of the material retrieved from the biotin pulldown may be a helpful indicator of how many additional, non-biotinylated potential partners were fished.

The Coomassie Blue SDS-PAGE gel used for the pull-downs contained many background bands in both control and experimental samples but did not reveal specific protein bands of low abundance. We therefore decided not to include this gel into the manuscript.

The authors also validate the interaction by co-expression and immunofluorescence, which reveals a very convincing, extensive co-localization in cytoplasmic blobs. As expected from literature, SSX2IP is absent from the cell junctions, however one may have hoped that the Wtip-SSX2IP colocalization would happen in basal bodies.

I have here two comments:

1) Co-localization should also be performed using full length Wtip, not only its N-terminus.

Prompted by the reviewer, we expressed full-length Wtip to determine whether it co-distributes with SSX2IP. Whereas WtipN and SSX2IP colocalized in many cytoplasmic puncta, full-length Wtip exhibited only partial colocalization in this assay. This finding is consistent with our immunoprecipitation data (Fig. 4) and supports a model, in which the excess of Wtip adopts a ‘closed’ conformation in the cell. These results are now presented in the new Fig. 5, and discussed on pp. 11-12, and p. 14, bottom.

2) The large number and the size of the blobs can be obviously explained by the high level of overexpression. The amount of mRNA injected (4x300pg for each of the component) is very high. It is fully justified for the pulldown as well as validation of the interaction, but using lower amounts (say 4x50, max 4x100pg) would be likely to reveal a more physiological distribution/co-localization.

As suggested by the reviewer, we injected lower doses (50 pg) of RNAs to study GFP-SSX2IP, RFP-Wtip and HA-RFP-WtipN protein localization during gastrulation. At lower doses of RNAs, the puncta of Wtip and SSX2IP were smaller in size (compare new Fig. 5 and Suppl. Fig. 1). In early gastrulae (stage 10.5), SSX2IP and Wtip were found in puncta near the cortex, but the puncta became more cytoplasmic at stage 12.5 (new Fig. 5).

Although the observed puncta may be non-physiological, this assay allows us to demonstrate the interaction of the two ectopic proteins in the tissue. In this case, the ectopic location is critical for establishing the interaction. Conversely, the co-distribution to basal bodies, in which Wtip and SSX2IP are normally found, would not prove the physical binding.

Finally, two comments on the functional tests using morpholinos:

1) The standard control for specificity of MO phenotypes is a rescue by co-injection of the corresponding mRNA. This is missing here. Of course, one may not expect full rescue, as dosage + spatial targeting could be tricky, yet even partial rescue would be OK.

We have done the experiment and have shown that human SSX2IP/Msd1 partly rescued neural tube closure defects of SSX2IP morphants. This is shown in revised Fig. 6 and discussed on p. 12, bottom.

2) Wtip - SSX2IP co-depletion: It is here dangerous to talk about “synergy”. The results of these co-depletions could simply be explained by an additive effect. If the authors wish to argue for a functional interaction, they may want to decrease the doses of each morpholino, down to levels that show little to no phenotype when injected alone. A strong double-knock down phenotype would then be a better argument for synergistic effect.

The text has been amended to remove the description of the functional Wtip and SSX2IP interactions as ‘synergistic’.

Responses to the editorial comments

In the revised version of the manuscript, we have addressed the editor’s points that largely reiterate the concerns of reviewer 1.

--Please perform co-localization with full length Wtip.

As requested, we expressed full-length Wtip to determine whether it co-distributes with SSX2IP. Whereas WtipN and SSX2IP colocalized in many cytoplasmic puncta, full-length Wtip exhibited only partial colocalization in this assay (new Fig. 5, text on pp. 11-12, 14, bottom).

--Please try to use lower amounts of mRNA injected (say 4x50, max 4x100pg) to reveal a more physiological distribution/co-localization.

At lower, more physiological doses of RNAs (50 pg each), SSX2IP and Wtip were visible as cortical or cytoplasmic puncta at the beginning of gastrulation (stage 10.5), whereas the SSX2IP puncta were predominantly cytoplasmic at a later stage (stage 12.5) (new Fig. 5, Fig. S1). We acknowledge that the observed aggregates may be non-physiological, however, this assay allows us to demonstrate the interaction of the two ectopic proteins in the tissue.

--Please try to rescue MO phenotypes by co-injection of the corresponding mRNA.

We found that human SSX2IP partly rescued neural tube closure defects of SSX2IP morphants. This is shown in revised Fig. 6.

--Please revise the use of synergy to describe the effect of Wtip - SSX2IP co-depletion.

The description of the functional interactions as ‘synergistic’ has been removed.

Attachment

Submitted filename: RESPONSE to Review Final.docx

Decision Letter 1

Claude Prigent

12 Oct 2021

Identification of the centrosomal maturation factor SSX2IP as a Wtip-binding partner by targeted proximity biotinylation

PONE-D-21-20125R1

Dear Dr. Sokol,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Claude Prigent

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have satisfactorily answered to the reviewers comments, by including additional data and/or modifying the text

No further comment

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Acceptance letter

Claude Prigent

20 Oct 2021

PONE-D-21-20125R1

Identification of the centrosomal maturation factor SSX2IP as a Wtip-binding partner by targeted proximity biotinylation

Dear Dr. Sokol:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Claude Prigent

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Colocalization of SSX2IP and WtipN in ectoderm cells.

    A, Experimental scheme. RFP-WtipN RNA (300 pg) and GFP-XSSX2IP RNA (300 pg) were coinjected into four-cell embryos. When the embryos reached stage 12.5, they were fixed, and the ectodermal tissue was imaged. B, GFP-SSX2IP localization in ectoderm cells. SSX2IP colocalizes with WtipN in cytoplasmic puncta. C, RFPWtipN localization at the junctions and cytoplasmic puncta. D-D”, Coexpression of both proteins revealed mixed cytoplasmic aggregates (arrow). Scale bar, 15 μm. Data are representative of 3 independent experiments.

    (PDF)

    S2 Fig. Full gel images.

    (PDF)

    Attachment

    Submitted filename: PloSOne-Reis et al.docx

    Attachment

    Submitted filename: RESPONSE to Review Final.docx

    Data Availability Statement

    All relevant data are within the paper.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES